Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2013-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6d02d62cb7810ebade3f738d27edd44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e8be8d1bb5d5f3bc10ebc6906806317 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e365f8954f322d57202a11182cac98dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521e24546f340c591f5d517391f8aa72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_841b19a790c78cc384a1b13d975fcbe1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1af9224a100b51a6bb94ebae7862419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a75f2cfb9b8648c2578fd422b8e31bcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349fb5a695630e6e4ca68332d731400f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d2a27e5fe3a7e14cd85c31b6c372bd4 |
publicationDate |
2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
IN-2014DN06939-A |
abstract |
Provided is a sustained release oral solid preparation comprising aripiprazole or a salt thereof as an active ingredient described below and a method for producing the sustained release oral solid preparation. A sustained release oral solid preparation comprising aripiprazole or a salt thereof and a sustained release excipient the sustained release excipient comprising a gelling agent; at least one inert pharmaceutical diluent selected from the group consisting of monosaccharides disaccharides polyhydric alcohols and mixtures thereof; and a pharmaceutically acceptable cationic cross linking agent capable of crosslinking with the gelling agent and increasing the gel strength when the sustained release oral solid preparation is exposed to an environmental fluid the gelling agent comprising xanthan gum and locust bean gum the ratio of the xanthan gum to the locust bean gum in the gelling agent being about 1:1 to 1:3 by weight the ratio of the inert pharmaceutical diluent to the gelling agent being about 1:1 to 1:2 by weight. |
priorityDate |
2012-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |